SCHEMBL206578

SCHEMBL206578

Cc1cccc(CC2(N(C)C)CCC(NC(=O)CCC(=O)NCCc3ccc(Cl)cc3)CC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
CNR1 P21554 1/20 0.45
RXFP1 Q9HBX9 1/20 0.43
MAPT P10636 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
SSTR1 P30872 1/20 0.42
SSTR4 P31391 1/20 0.42
EPHX1 P07099 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
KMT2A Q03164 3/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206288 0.93 ALDH1A1 (0.50) ALDH1A1CNR1RXFP1MAPTHDAC3
SCHEMBL206988 0.93 ALDH1A1 (0.51) ALDH1A1CNR1RXFP1MAPTEPHX1
SCHEMBL206736 0.93 HPGD (0.48) ALDH1A1HDAC3HDAC1HDAC2HDAC10
Hydrochloric Acid SCHEMBL206061 0.92 ALDH1A1 (0.50) ALDH1A1CNR1RXFP1MAPTEPHX1
SCHEMBL207253 0.91 HDAC3 (0.43) ALDH1A1CNR1HDAC3HDAC1HDAC2
SCHEMBL4084112 0.91 HPGD (0.45) ALDH1A1HDAC3HDAC1HDAC2HDAC10
SCHEMBL207134 0.91 HPGD (0.43) ALDH1A1MAPTHDAC3HDAC1HDAC2
SCHEMBL208300 0.90 LMNA (0.50) ALDH1A1CNR1EPHX1LMNAPOLB
SCHEMBL205392 0.90 HPGD (0.46) ALDH1A1CNR1MAPTHDAC3HDAC1
SCHEMBL205662 0.89 HDAC3 (0.40) ALDH1A1CNR1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885CNR1 737/4885RXFP1 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.